Health
Retatrutide Explained: What the Trials Show, and Why “Research Peptide” Versions Are Risky
Lilly’s triple-hormone drug produced some of the largest weight loss ever seen in obesity trials. It isn’t approved yet — and a fast-growing online market selling it as a “research peptide” carries real dangers.